Rezultati pretrage - Pierfranco Conté

Detaljiziraj rezultate
  1. 1
    Safety of Intravenous and Oral Bisphosphonates and Compliance With Dosing Regimens

    Safety of Intravenous and Oral Bisphosphonates and Compliance With Dosing Regimens od Pierfranco Conté, Valentina Guarneri

    Izdano 2004
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  2. 2
    Metastatic Breast Cancer: Therapeutic Options According to Molecular Subtypes and Prior Adjuvant Therapy

    Metastatic Breast Cancer: Therapeutic Options According to Molecular Subtypes and Prior Adjuvant Therapy od Valentina Guarneri, Pierfranco Conté

    Izdano 2009
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  3. 3
    Real-World Evidence in Oncology: Opportunities and Limitations

    Real-World Evidence in Oncology: Opportunities and Limitations od Massimo Di Maïo, Francesco Perrone, Pierfranco Conté

    Izdano 2019
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  4. 4
    Effects of Sulfonylureas on Tumor Growth: A Review of the Literature

    Effects of Sulfonylureas on Tumor Growth: A Review of the Literature od Giulia Pasello, Loredana Urso, Pierfranco Conté, Adolfo Favaretto

    Izdano 2013
    Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  5. 5
    Heterogeneity of Multipotent Mesenchymal Stromal Cells: From Stromal Cells to Stem Cells and Vice Versa

    Heterogeneity of Multipotent Mesenchymal Stromal Cells: From Stromal Cells to Stem Cells and Vice Versa od Massimo Dominici, Paolo Paolucci, Pierfranco Conté, Edwin M. Horwitz

    Izdano 2009
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  6. 6
    Rare Breast Cancer Subtypes: Histological, Molecular, and Clinical Peculiarities

    Rare Breast Cancer Subtypes: Histological, Molecular, and Clinical Peculiarities od Maria Vittoria Dieci, Enrico Orvieto, Massimo Dominici, Pierfranco Conté, Valentina Guarneri

    Izdano 2014
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  7. 7
    Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges

    Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges od Alberto Pavan, Ilaria Attili, Giulia Pasello, Valentina Guarneri, Pierfranco Conté, Laura Bonanno

    Izdano 2019
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  8. 8
    Cognitive impairment following breast cancer treatments: an umbrella review

    Cognitive impairment following breast cancer treatments: an umbrella review od Giulia Oliva, Andreina Giustiniani, Laura Danesin, Francesca Burgio, Giorgio Arcara, Pierfranco Conté

    Izdano 2024
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  9. 9
    Posterior Reversible Encephalopathy Syndrome During Ipilimumab Therapy for Malignant Melanoma

    Posterior Reversible Encephalopathy Syndrome During Ipilimumab Therapy for Malignant Melanoma od Michela Maur, Chiara Tomasello, Antonio Frassoldati, Maria Vittoria Dieci, Elena Barbieri, Pierfranco Conté

    Izdano 2011
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  10. 10
    Survival after neoadjuvant therapy with trastuzumab–lapatinib and chemotherapy in patients with HER2-positive early breast cancer: a meta-analysis of randomized trials

    Survival after neoadjuvant therapy with trastuzumab–lapatinib and chemotherapy in patients with HER2-positive early breast cancer: a meta-analysis of randomized trials od Valentina Guarneri, Gaia Griguolo, Federica Miglietta, Pierfranco Conté, Maria Vittoria Dieci, Fabio Girardi

    Izdano 2022
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  11. 11
    Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide

    Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide od Serafino Ricci, Andrea Antonuzzo, Luca Galli, M Ferdeghini, Lisa Bodei, Cinzia Orlandini, Pierfranco Conté

    Izdano 2000
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  12. 12
    LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung Cancer

    LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung Cancer od Laura Bonanno, Elisabetta Zulato, Alberto Pavan, Ilaria Attili, Giulia Pasello, Pierfranco Conté, Stefano Indraccolo

    Izdano 2019
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  13. 13
    Examining technology-assisted rehabilitation for older adults’ functional mobility: a network meta-analysis on efficacy and acceptability

    Examining technology-assisted rehabilitation for older adults’ functional mobility: a network meta-analysis on efficacy and acceptability od Błażej Cieślik, Justyna Mazurek, Adam Wrzeciono, Lorenza Maistrello, Joanna Szczepańska-Gieracha, Pierfranco Conté, Paweł Kiper

    Izdano 2023
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  14. 14
    Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials

    Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials od Maria Vittoria Dieci, M.‐C. Mathieu, Valentina Guarneri, Pierfranco Conté, Suzette Delaloge, Fabrice André, Aïcha Goubar

    Izdano 2015
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  15. 15
    Real world data in the era of Immune Checkpoint Inhibitors (ICIs): Increasing evidence and future applications in lung cancer

    Real world data in the era of Immune Checkpoint Inhibitors (ICIs): Increasing evidence and future applications in lung cancer od Giulia Pasello, Alberto Pavan, Ilaria Attili, Alberto Bortolami, Laura Bonanno, Jessica Menis, Pierfranco Conté, Valentina Guarneri

    Izdano 2020
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  16. 16
    Lack of Benefit of Maintenance Paclitaxel in First-Line Chemotherapy in Metastatic Breast Cancer

    Lack of Benefit of Maintenance Paclitaxel in First-Line Chemotherapy in Metastatic Breast Cancer od Alessandra Gennari, Dino Amadori, Mario De Lena, Oriana Nanni, Paolo Bruzzi, Vito Lorusso, Luigi Manzione, Pierfranco Conté

    Izdano 2006
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  17. 17
    Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-Institution analysis

    Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-Institution analysis od Maria Vittoria Dieci, Elena Barbieri, Federico Piacentini, Guido Ficarra, Stefania Bettelli, Massimo Dominici, Pierfranco Conté, Valentina Guarneri

    Izdano 2012
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  18. 18
    Donor cell–derived osteopoiesis originates from a self-renewing stem cell with a limited regenerative contribution after transplantation

    Donor cell–derived osteopoiesis originates from a self-renewing stem cell with a limited regenerative contribution after transplantation od Massimo Dominici, Roberta Marino, Valeria Rasini, Carlotta Spano, Paolo Paolucci, Pierfranco Conté, Ted J. Hofmann, Edwin M. Horwitz

    Izdano 2008
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  19. 19
    Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based chemotherapy: an Italian Collaborative Study from the ‘Mario Negri’ Institute, Milan, G.O.N.O. (Gruppo Oncologico Nord Ovest) group and I.O.R. (Istituto Oncologico Romagnolo) group

    Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based c... od Alessandro Buda, Irene Floriani, R Rossi, Nicoletta Colombo, Valter Torri, Pierfranco Conté, R. Fossati, Alessandra Ravaioli, Costantino Mangioni

    Izdano 2004
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  20. 20
    Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg?

    Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg? od Laura Bonanno, Alessandro Dal Maso, Alberto Pavan, Elisabetta Zulato, Lorenzo Calvetti, Giulia Pasello, Valentina Guarneri, Pierfranco Conté, Stefano Indraccolo

    Izdano 2022
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:

Alati za pretragu: